Pfizer reports disappointing trial results for a breast cancer drug. Chipotle rises on an analyst upgrade.
- Where you bank can make a big difference for racial justice
- Think tank explains why it’s ‘pointless’ to delist Chinese companies from U.S. stock markets
- IPOs in Hong Kong and Shanghai pop, despite pandemic, tensions with the U.S.
- Unemployment is falling. But it may be short-lived: ‘There’s no cause for celebration’
- Stocks making the biggest moves in the premarket: McDonald’s, Tesla, JetBlue, Facebook & more